全球公共卫生治理视野下的“新冠肺炎疫苗实施计划”

“THE COVID-19 VACCINES GLOBAL ACCESS FACILITY”:FROM A PERSPECTIVE OF GLOBAL PUBLIC HEALTH GOVERNANCE

“新冠肺炎疫苗实施计划”旨在让世界各国尤其是中低收入国家公平接种新冠肺炎疫苗。此计划在技术支持、资金筹集、分配机制和疫后经济恢复规划方面都取得积极进展。该机制有效提升了全球公共卫生治理能力,在分散疫苗研发风险、协调全球供应链和深化公私伙伴关系方面发挥了良好的示范作用,体现了公共卫生合作的“总观效应”。但是,面对国家利益优先、对于分配原则的质疑和“疫苗犹豫”等一系列问题,“新冠肺炎疫苗实施计划”的效果还需要在实践中得到检验。

The COVID-19 Vaccines Global Access Facility aims to provide equitable access to COVID-19 vaccines around the world,especially in low-and-middle income countries.COVAX has made great progress in technical support,funding,distribution mechanisms and planning of economic recovery.It has improved the global public health governance,set a model in reducing the risk of vaccine research,coordinating global supply chains and deepening public-private partnerships,demonstrating the“Overview Effect”of public health cooperation.However,COVAX also faces some problems,such as priority of national interests,the question about the principle of distribution and“Vaccine Hesitancy”,which will decide the effect in the practice.